<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-K2VR3P9A</identifier><date>2000</date><creator>Čufer, Tanja</creator><relation>documents/doc/K/URN_NBN_SI_doc-K2VR3P9A_001.pdf</relation><relation>documents/doc/K/URN_NBN_SI_doc-K2VR3P9A_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 98-108</format><identifier identifier_type="COBISSID_HOST">13135321</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-K2VR3P9A</identifier><language>slv</language><publisher>Onkološki inštitut</publisher><source>Priročnik iz onkološke zdravstvene nege in onkologije</source><rights>InC</rights><subject language_type_id="slv">Antineoplastic agents</subject><subject language_type_id="slv">Drug therapy</subject><subject language_type_id="slv">Immunotherapy</subject><subject language_type_id="slv">Neoplasms</subject><title>Sistemsko zdravljenje raka</title></Record>